Abstract
Bipolar disorder (BD) is a chronic mental disease that substantially affects the patient’s quality of life and causes significant morbidity and mortality. Although there are a variety of available treatments, therapeutic intervention is not beneficial in many cases and recurrence rates remain high. Recent data suggested tamoxifen, a drug with a wide range of activities, as a potential treatment for reducing manic symptoms of BD. Tamoxifen’s therapeutic effect on bipolar mania has not been fully elucidated, but it is believed to biochemically operate on protein kinase C (PKC) inhibition. In this article, we review preclinical and clinical studies investigating the efficacy of tamoxifen as a potential treatment for bipolar manic patients.
| Original language | English |
|---|---|
| Pages (from-to) | 344-352 |
| Number of pages | 9 |
| Journal | Psychiatry and Clinical Psychopharmacology |
| Volume | 31 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1 Jan 2021 |
Keywords
- Antimanic treatment
- bipolar disorder
- mania
- protein kinase C
- tamoxifen
ASJC Scopus subject areas
- Psychiatry and Mental health
- Pharmacology (medical)